1. Home
  2. IOVA vs THR Comparison

IOVA vs THR Comparison

Compare IOVA & THR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IOVA
  • THR
  • Stock Information
  • Founded
  • IOVA 2007
  • THR 1954
  • Country
  • IOVA United States
  • THR United States
  • Employees
  • IOVA N/A
  • THR N/A
  • Industry
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • THR Industrial Machinery/Components
  • Sector
  • IOVA Health Care
  • THR Energy
  • Exchange
  • IOVA Nasdaq
  • THR Nasdaq
  • Market Cap
  • IOVA 771.4M
  • THR 887.4M
  • IPO Year
  • IOVA N/A
  • THR 2011
  • Fundamental
  • Price
  • IOVA $1.98
  • THR $27.00
  • Analyst Decision
  • IOVA Buy
  • THR
  • Analyst Count
  • IOVA 10
  • THR 0
  • Target Price
  • IOVA $12.22
  • THR N/A
  • AVG Volume (30 Days)
  • IOVA 11.2M
  • THR 254.1K
  • Earning Date
  • IOVA 08-07-2025
  • THR 08-06-2025
  • Dividend Yield
  • IOVA N/A
  • THR N/A
  • EPS Growth
  • IOVA N/A
  • THR 3.97
  • EPS
  • IOVA N/A
  • THR 1.57
  • Revenue
  • IOVA $212,679,000.00
  • THR $498,207,000.00
  • Revenue This Year
  • IOVA $86.62
  • THR $6.11
  • Revenue Next Year
  • IOVA $69.95
  • THR $5.40
  • P/E Ratio
  • IOVA N/A
  • THR $17.25
  • Revenue Growth
  • IOVA 11070.12
  • THR 0.72
  • 52 Week Low
  • IOVA $1.64
  • THR $23.05
  • 52 Week High
  • IOVA $12.51
  • THR $34.36
  • Technical
  • Relative Strength Index (RSI)
  • IOVA 43.44
  • THR 45.87
  • Support Level
  • IOVA $1.95
  • THR $26.92
  • Resistance Level
  • IOVA $2.47
  • THR $27.70
  • Average True Range (ATR)
  • IOVA 0.15
  • THR 0.62
  • MACD
  • IOVA 0.05
  • THR -0.03
  • Stochastic Oscillator
  • IOVA 35.53
  • THR 53.19

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

About THR Thermon Group Holdings Inc.

Thermon Group Holdings Inc is a United States-based company that provides engineered thermal solutions for process industries. The company's product portfolio comprises electric heat tracing cables, steam tracing components, tubing bundles, and instrument and control products, as well as complementary product lines. It also provides turnkey services and design and engineering services. The company's customers include large engineering, procurement, and construction companies; oil and gas companies; commercial subcontractors; electrical component distributors; and others. The company has a presence, with the United States, Canada, and Europe being its top three markets and contributing the majority of its sales.

Share on Social Networks: